FDA NDC Directory · JSON-LD · Markdown

evolocumab

NDC 68225-262 · DRUG FOR FURTHER PROCESSING · INJECTION, SOLUTION

Labeler / ManufacturerPatheon Italia S.p.A.
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeINJECTION, SOLUTION
Active ingredientsEVOLOCUMAB (140 mg/mL)
Marketing started20260603
Package count1

External sources

Source: openFDA. Public-domain (CC0).